|
|
 |
|
Viewing report
|
|
 |
 |
The Pharmaceutical Industry Paradox: A Strategic Analysis Of The Countertrends Of Consolidation And Fragmentation
Business Insights, May 2002
The pharmaceutical industry currently represents a huge paradox. Whilst the pursuit of critical mass has driven consolidation and brought about the creation of mega-companies such as Pharmacia, GlaxoSmithKline and Pfizer, the industry as a whole and its markets remain highly fragmented. Similarly, consolidated companies have missed opportunities to re-engineer their processes, build greater brand effectiveness and, in fact, remain fragmented internally. The new report provides critical insights into the marketing and R&D implications of these key industry shifts. The report utilises an extensive survey of industry executives to pinpoint the strategic implications for industry players, providing the key data and analysis of strategies adopted by leading companies seeking to optimise both their current position and future prospects.
Customers who bought this item also bought
The Pharmaceutical Industry: Key Trends and Strategic Issues Shaping the Industry.
The GPL paradox: polarisation and flexibility
Business Intelligence: Consolidation and Beyond (Strategic Focus)
Global Recruitment Market: Highly Fragmented Market Creates Opportunities
Indian Pharmaceutical Industry
The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma
eHealthInsight Series: Online Pharmacies - Implications for the Pharmaceutical Industry
An Exploration of Consolidation in the Generics Industry
State of the Pharmaceutical Industry 2008
Indian Pharmaceutical Industry: Strategies, Trends and Opportunities
The Consolidation of the Information Industry-A Paradigm Shift
State of the Pharmaceutical Industry, 2007
|
 |
|
|